Assessment of peripheral blood lymphocyte subsets in idiopathic myelofibrosis

European Journal of Haematology

Volumn 65, Issue 2, 2000, Pages 104-108

  Cervantes, Francisco ^a,b   Hernández Boluda, Juan Carlos ^a   Villamor, Neus ^a   Serra, Angélica ^a   Montserrat, Emilio ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

Agnogenic myeloid metaplasia; CD5 positive B cells; Idiopathic myelofibrosis; Immunology; Lymphocyte subsets

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DIAGNOSTIC VALUE; FEMALE; HUMAN; LYMPHOCYTE COUNT; LYMPHOCYTE SUBPOPULATION; LYMPHOCYTOPENIA; MALE; MYELOFIBROSIS; PRIORITY JOURNAL;

ADULT; AGED; BIOPSY; BONE MARROW; FEMALE; HUMANS; IMMUNOPHENOTYPING; LYMPHOCYTE COUNT; LYMPHOCYTE SUBSETS; MALE; MIDDLE AGED; MYELOFIBROSIS;

EID: 0033867075     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0609.2000.90262.x     Document Type: Article

References (26)

1. Myelofibrosis: Clinical, hematologic and pathologic study of 110 patients
2. Working formulation of chronic myeloproliferative disorders based on histological, haematological, and clinical findings
3. Agnogenic myeloid metaplasia: A clonal proliferation of hematopoietic stem cells with secondary myelofibrosis
4. Immune complexes in myelofibrosis: A possible guide to management
5. Idiopathic myelofibrosis: A possible role for immune complexes in the pathogenesis of bone marrow fibrosis
6. Immunologic abnormalities in myelofibrosis with activation of the complement system
7. Immune disorders in agnogenic myeloid metaplasia: Relations to myelofibrosis
8. Bone marrow lymphoid nodules in myeloproliferative disorders: Association with the nonmyelosclerotic phases of idiopathic myelofibrosis and immunological significance
9. Scleroderma associated with idiopathic myelofibrosis
10. Myelofibrosis and systemic lupus erythematosus: Reversal of fibrosis with high-dose corticosteroid therapy
11. Autoimmune myelofibrosis. A steroid-responsive cause of bone marrow fibrosis associated with systemic lupus erythematosus
12. Myelofibrosis and idiopathic thrombocytopenic purpura
13. CD5 B cells in autoimmune and non-immune-mediated thyroid dysfunctions
14. Lymphocyte subpopulations in peripheral blood and bone marrow in patients with idiopathic myelofibrosis
15. Identification of 'short-lived' and 'long-lived' patients at presentation of idiopathic myelofibrosis
16. Patho-anatomical features of the bone marrow
17. A simple salting out procedure for extracting DNA from human nucleated cells
18. Evaluation of residual disease in B-cell chronic lymphocytic leukemia patients in clinical and bone marrow remission using CD5-CD19 markers and PCR study of gene rearrangements
19. Circulating immune complexes in myelofibrosis
20. Immunological abnormalities in myelofibrosis
21. Mega-dose intravenous methylprednisolone in adult idiopathic myelofibrosis
22. Cancer immunology: The search for specificity
23. CD5+ B lymphocytes, polyreactive antibodies and the human B-cell repertoire
24. A rheumatoid arthritis B cell subset express a phenotype similar to that in chronic lymphocytic leukemia
25. B cells expressing CD5 are increased in Sjogren's syndrome
26. Clonal B-cell populations in patients with idiopathic thrombocytopenic purpura